S. Suissa
New England Journal of Medicine · 2001–2019
A researcher in the Science corpus: 8 papers; trusts 0 researchers and is trusted by 10 researchers here, as inferred from the citation graph.
Who trusts S. Suissa overall
Papers from S. Suissa's perspective
Ordered by how strongly the researchers S. Suissa trusts endorse each paper. Same corpus, a different order for every researcher.
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease (Thorax)
- Susceptibility to exacerbation in chronic obstructive pulmonary disease. (New England Journal of Medicine)
- The Statistical Analysis of Failure Time Data (Technometrics)
- Statin use and reduced cancer-related mortality. (New England Journal of Medicine)
- Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
- Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
- Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. (American Journal of Respiratory and Critical Care Medicine)
- Toward a consensus definition for COPD exacerbations. (Chest)
Their papers
- Immortal time bias in pharmaco-epidemiology. (2008) — 1,615 citations
- Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals (2019) — 599 citations
- Use of statins and the risk of death in patients with prostate cancer. (2014) — 674 citations
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality (2012) — 781 citations
- Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes (2010) — 1,122 citations
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes (2009) — 686 citations
- Dopamine agonists and the risk of cardiac-valve regurgitation. (2007) — 649 citations
- A clinical trial of estrogen-replacement therapy after ischemic stroke. (2001) — 830 citations